Tangshan Central Hospital
Tangshan Central Hospital
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, hematologic disorder, leukemia, neoplasm | Not yet recruiting | Not stated | 2024-10-18 | NCT06649422 | |
| Complete Revascularization Via Inferior Part-sternotomy | Complete Revascularization; Coronary Artery Bypass Grafting; Multivessel Coronary Artery Disease | Not yet recruiting | Not applicable | 2023-04-28 | NCT05835167 |